Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
0%
0%
0.0%
6 Months
0%
0%
0.0%
1 Year
-33.33%
0%
-33.33%
2 Years
-99.95%
0%
-99.95%
3 Years
-99.99%
0%
-99.99%
4 Years
-100.0%
0%
-100.0%
5 Years
-100.0%
0%
-100.0%
UpHealth, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
207.02%
EBIT Growth (5y)
-174.17%
EBIT to Interest (avg)
-1.84
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.26
Sales to Capital Employed (avg)
0.52
Tax Ratio
5.75%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
34.60%
ROCE (avg)
0
ROE (avg)
7.40%
Valuation key factors
Factor
Value
P/E Ratio
Industry P/E
Price to Book Value
EV to EBIT
6.01
EV to EBITDA
-3.35
EV to Capital Employed
-0.35
EV to Sales
-0.24
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
36.73%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
Bearish
Bollinger Bands
Sideways
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot : Mar 2024
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 8 Schemes (2.71%)
Foreign Institutions
Held by 7 Foreign Institutions (0.72%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Mar'24 - QoQ
Mar'24
Dec'23
Change(%)
Net Sales
0.00
17.30
-100.00%
Operating Profit (PBDIT) excl Other Income
-5.00
0.90
-655.56%
Interest
5.50
7.50
-26.67%
Exceptional Items
-0.20
-4.20
95.24%
Consolidate Net Profit
-11.90
-10.00
-19.00%
Operating Profit Margin (Excl OI)
0.00%
-63.80%
6.38%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2024 is -100.00% vs -47.09% in Dec 2023
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2024 is -19.00% vs 50.25% in Dec 2023
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
130.00
158.80
-18.14%
Operating Profit (PBDIT) excl Other Income
17.40
-3.20
643.75%
Interest
28.20
26.50
6.42%
Exceptional Items
-94.40
-143.20
34.08%
Consolidate Net Profit
-56.40
-222.90
74.70%
Operating Profit Margin (Excl OI)
37.40%
-157.70%
19.51%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is -18.14% vs 28.27% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is 74.70% vs 34.61% in Dec 2022
About UpHealth, Inc. 
UpHealth, Inc.
Pharmaceuticals & Biotechnology
Gigcapital2, Inc. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization, recapitalization or other similar business combination with one or more businesses. The Company’s initial business combination is not limited to any business, industry or geographic location, and intends to identify, acquire and operate a business in the thermos mechanical treatment (TMT) industry. The Company is not engaged in any business operations and has not generated any revenue.
Company Coordinates 
Company Details
2479 E Bayshore Rd Ste 200 , PALO ALTO CA : 94303-3244
Registrar Details






